Flavonoids and Other Polyphenols Act As Epigenetic Modifiers in Breast Cancer

Overview

Journal Nutrients

Date 2020 Mar 19

PMID 32183060

Citations 64

Authors

Priyanga Selvakumar

Aja Badgeley

Paige Murphy

Hina Anwar

Urvashi Sharma

Katharine Lawrence

Ashakumary Lakshmikuttyamma

Affiliations

Soon will be listed here.

Abstract

Breast cancer is a common cancer that occurs due to different epigenetic alterations and genetic mutations. Various epidemiological studies have demonstrated an inverse correlation between breast cancer incidence and flavonoid intake. The anti-cancer action of flavonoids, a class of polyphenolic compounds that are present in plants, as secondary metabolites has been a major topic of research for many years. Our review analysis demonstrates that flavonoids exhibit anti-cancer activity against breast cancer occurring in different ethnic populations. Breast cancer subtype and menopausal status are the key factors in inducing the flavonoid's anti-cancer action in breast cancer. The dose is another key factor, with research showing that approximately 10 mg/day of isoflavones is required to inhibit breast cancer occurrence. In addition, flavonoids also influence the epigenetic machinery in breast cancer, with research demonstrating that epigallocatechin, genistein, and resveratrol all inhibited DNA methyltransferase and altered chromatin modification in breast cancer. These flavonoids can induce the expression of different tumor suppressor genes that may contribute to decreasing breast cancer progression and metastasis. Additional studies are required to confirm the contribution of epigenetic modifications by flavonoids to breast cancer prevention.

Citing Articles

Oral intake of Hibiscus sabdariffa L. increased c-Myc and caspase-3 gene expression and altered microbial population in colon of BALB/c mice induced to preneoplastic lesions.

Ladeira Bernardes A, Albuquerque Pereira M, Xisto Campos I, Avila L, Dos Santos Cruz B, Duarte Villas Mishima M Eur J Nutr. 2025; 64(3):109.

PMID: 40042671 DOI: 10.1007/s00394-025-03622-z.

Resveratrol contributes to NK cell-mediated breast cancer cytotoxicity by upregulating ULBP2 through miR-17-5p downmodulation and activation of MINK1/JNK/c-Jun signaling.

Ding B, Li J, Yan J, Jiang C, Qian L, Pan J Front Immunol. 2025; 16:1515605.

PMID: 39963142 PMC: 11830804. DOI: 10.3389/fimmu.2025.1515605.

Bee Pollen Phytochemicals and Nutrients as Unequaled Pool of Epigenetic Regulators: Implications for Age-Related Diseases.

Kacemi R, Campos M Foods. 2025; 14(3).

PMID: 39941940 PMC: 11816923. DOI: 10.3390/foods14030347.

Methanolic Leaves Extract of Inhibits Cell Proliferation and Migration of HER2-Positive Breast Cancer via p38 MAPK Signaling Pathway.

Saeed S, Hassan A, Suliman A, Moustafa A, Alali F Int J Mol Sci. 2025; 26(2).

PMID: 39859369 PMC: 11765879. DOI: 10.3390/ijms26020654.

An updated review summarizing the anticancer potential of flavonoids via targeting NF-kB pathway.

Pandey P, Lakhanpal S, Mahmood D, Kang H, Kim B, Kang S Front Pharmacol. 2025; 15():1513422.

PMID: 39834817 PMC: 11743680. DOI: 10.3389/fphar.2024.1513422.

References

Eom G, Kook H . Posttranslational modifications of histone deacetylases: implications for cardiovascular diseases. Pharmacol Ther. 2014; 143(2):168-80. DOI: 10.1016/j.pharmthera.2014.02.012. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2018. CA Cancer J Clin. 2018; 68(1):7-30. DOI: 10.3322/caac.21442. View

Oh J, Sandin S, Strom P, Lof M, Adami H, Weiderpass E . Prospective study of breast cancer in relation to coffee, tea and caffeine in Sweden. Int J Cancer. 2015; 137(8):1979-89. DOI: 10.1002/ijc.29569. View

Greenup R, Buchanan A, Lorizio W, Rhoads K, Chan S, Leedom T . Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort. Ann Surg Oncol. 2013; 20(10):3254-8. DOI: 10.1245/s10434-013-3205-1. View

Higdon J, Frei B . Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr. 2003; 43(1):89-143. DOI: 10.1080/10408690390826464. View

Gao Y, Tollefsbol T . Combinational Proanthocyanidins and Resveratrol Synergistically Inhibit Human Breast Cancer Cells and Impact Epigenetic⁻Mediating Machinery. Int J Mol Sci. 2018; 19(8). PMC: 6121898. DOI: 10.3390/ijms19082204. View

Lopez-Camarillo C, Gallardo-Rincon D, Alvarez-Sanchez M, Marchat L . Pharmaco-epigenomics: On the Road of Translation Medicine. Adv Exp Med Biol. 2019; 1168:31-42. DOI: 10.1007/978-3-030-24100-1_3. View

Reglero C, Reglero G . Precision Nutrition and Cancer Relapse Prevention: A Systematic Literature Review. Nutrients. 2019; 11(11). PMC: 6893579. DOI: 10.3390/nu11112799. View

Romagnolo D, Donovan M, Papoutsis A, Doetschman T, Selmin O . Genistein Prevents CpG Methylation and Proliferation in Human Breast Cancer Cells with Activated Aromatic Hydrocarbon Receptor. Curr Dev Nutr. 2018; 1(6):e000562. PMC: 5998349. DOI: 10.3945/cdn.117.000562. View

10.

Janle E, Morre D, Morre D, Zhou Q, Zhu Y . Pharmacokinetics of green tea catechins in extract and sustained-release preparations. J Diet Suppl. 2009; 5(3):248-63. PMC: 2747776. DOI: 10.1080/19390210802414279. View

11.

Lee K, Kuo Y, Ho Y, Huang Y . Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness. Cancers (Basel). 2019; 11(9). PMC: 6769912. DOI: 10.3390/cancers11091334. View

12.

Song K, Atkinson C, Frankenfeld C, Jokela T, Wahala K, Thomas W . Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls. J Nutr. 2006; 136(5):1347-51. DOI: 10.1093/jn/136.5.1347. View

13.

Yoon S, Eom G . HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases. Chonnam Med J. 2016; 52(1):1-11. PMC: 4742605. DOI: 10.4068/cmj.2016.52.1.1. View

14.

Lewis K, Jordan H, Tollefsbol T . Effects of SAHA and EGCG on Growth Potentiation of Triple-Negative Breast Cancer Cells. Cancers (Basel). 2018; 11(1). PMC: 6356328. DOI: 10.3390/cancers11010023. View

15.

Sheng J, Shi W, Guo H, Long W, Wang Y, Qi J . The Inhibitory Effect of (-)-Epigallocatechin-3-Gallate on Breast Cancer Progression via Reducing Methylation and DNMT Activity. Molecules. 2019; 24(16). PMC: 6719997. DOI: 10.3390/molecules24162899. View

16.

Shu X, Zheng Y, Cai H, Gu K, Chen Z, Zheng W . Soy food intake and breast cancer survival. JAMA. 2009; 302(22):2437-43. PMC: 2874068. DOI: 10.1001/jama.2009.1783. View

17.

Egert S, Wolffram S, Bosy-Westphal A, Boesch-Saadatmandi C, Wagner A, Frank J . Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J Nutr. 2008; 138(9):1615-21. DOI: 10.1093/jn/138.9.1615. View

18.

Jeong J, An J, Kwon Y, Rhee J, Lee Y . Effects of low dose quercetin: cancer cell-specific inhibition of cell cycle progression. J Cell Biochem. 2008; 106(1):73-82. PMC: 2736626. DOI: 10.1002/jcb.21977. View

19.

Iwasaki M, Inoue M, Sasazuki S, Sawada N, Yamaji T, Shimazu T . Green tea drinking and subsequent risk of breast cancer in a population-based cohort of Japanese women. Breast Cancer Res. 2012; 12(5):R88. PMC: 3096981. DOI: 10.1186/bcr2756. View

20.

Shang S, Hua F, Hu Z . The regulation of β-catenin activity and function in cancer: therapeutic opportunities. Oncotarget. 2017; 8(20):33972-33989. PMC: 5464927. DOI: 10.18632/oncotarget.15687. View